NMN and PARP1: How NAD+ Powers Your DNA Repair System
Every cell in your body sustains between 10,000 and 100,000 DNA damage events per day. Most are repaired within minutes. The enzyme primarily responsible for detecting and initiating that repair is PARP1 — poly-ADP-ribose polymerase 1. And PARP1 cannot function without NAD+.
This connection between NAD+, PARP1, and DNA repair is one of the most studied mechanisms in ageing biology.
It explains why NAD+ decline accelerates genomic instability. It explains why the relationship between DNA damage and energy depletion is not coincidental. And it identifies a specific, mechanistic rationale for why restoring NAD+ through nicotinamide mononucleotide is studied as a strategy for supporting healthy DNA maintenance in ageing cells.
What PARP1 Does and Why NAD+ Is Its Fuel
PARP1 is a nuclear enzyme that functions as a damage sensor. When a DNA strand break occurs — from oxidative stress, ionising radiation, ultraviolet light, or errors in DNA replication — PARP1 binds to the break site within seconds. It then synthesises long chains of poly-ADP-ribose (PAR chains) onto itself and nearby histones, recruiting the broader DNA repair machinery to the damage site.
How the process works:
- DNA strand break occurs
- PARP1 detects the break within seconds and binds to it
- PARP1 synthesises PAR chains, consuming multiple NAD+ molecules per chain
- PAR chains recruit repair proteins (XRCC1, DNA ligase III, DNA polymerase beta)
- Repair completes, PAR chains are degraded by PARG
- PARP1 is released, NAD+ pool is reduced
A single significant DNA repair event can consume hundreds of NAD+ molecules. In aged cells undergoing high levels of damage — as occurs with chronic oxidative stress — PARP1 activity is nearly continuous, creating a sustained drain on the cellular NAD+ pool.
Mat Stuckey, founder of Longevity Formulas: "The number that stopped me in my tracks was 10,000 to 100,000 DNA damage events per cell per day. Every single one of those events requires PARP1, and PARP1 requires NAD+. Once you understand that, the energy depletion that comes with ageing starts to make a lot more sense. It is not just that your mitochondria are less efficient. It is also that your DNA repair system is quietly consuming a huge proportion of your remaining NAD+."
The Competition Between PARP1 and Sirtuins for NAD+
PARP1 and the sirtuin family of deacetylases share the same substrate: NAD+. In young cells with adequate NAD+, both enzyme families operate efficiently.
| Enzyme | Primary function | NAD+ consumption pattern |
|---|---|---|
| PARP1 | DNA repair initiation | Acute, high-volume bursts at damage sites |
| SIRT1 | Gene expression, inflammation control, NAMPT upregulation | Tonic, continuous, moderate |
| SIRT3 | Mitochondrial protein deacetylation, ATP synthase function | Tonic, continuous, moderate |
| SIRT6 | Telomere maintenance, DNA double-strand break repair | Tonic, continuous, lower volume |
As NAD+ declines with age, these systems are forced to compete. PARP1 has a strong kinetic advantage because DNA damage is an acute threat that triggers immediate enzymatic activation. When PARP1 activates, it rapidly consumes local NAD+. Sirtuins, which operate continuously rather than in acute bursts, lose substrate and reduce their activity.
The result is what researchers describe as the PARP1-sirtuin trade-off. Cells prioritise DNA repair at the cost of sirtuin-mediated regulation. Reduced sirtuin activity then impairs mitochondrial function, increases inflammation, and reduces NAMPT transcription — all of which further deplete NAD+ and generate more oxidative stress, which causes more DNA damage, which activates more PARP1.
The Longevity Formulas team: "This feedback loop is one of the reasons we are genuinely interested in what we do — not just commercially but scientifically. The PARP1-sirtuin competition is an elegant example of how ageing is self-reinforcing at the molecular level. And the intervention point is one that is accessible: you can expand the NAD+ pool. You cannot stop DNA damage. But you can give the cell enough substrate that it does not have to choose between repairing DNA and regulating its own ageing biology."
Why DNA Damage Increases With Age
Three age-related changes converge to increase the total DNA damage burden that PARP1 must address.
Declining Mitochondrial Efficiency
Aged mitochondria generate more reactive oxygen species per unit of ATP produced. These ROS — including superoxide, hydrogen peroxide, and hydroxyl radicals — react with DNA bases and sugar-phosphate backbones, producing the oxidised lesions and strand breaks that PARP1 must repair.
Telomere Shortening
As telomeres erode with each cell division, telomere repeats eventually become too short to be distinguished from DNA double-strand breaks by the DNA damage response machinery. PARP1 treats critically short telomeres as damage events and mounts a persistent response — generating a background level of activation that cannot resolve because the underlying cause is not a reparable lesion.
Reduced Base Excision Repair Efficiency
Base excision repair (BER) is the primary pathway for correcting oxidative DNA damage early, before it progresses to a full strand break. Several BER enzymes are themselves impaired in aged tissue with reduced NAD+ availability. More lesions therefore escape early correction and progress to strand breaks requiring full PARP1-mediated repair — increasing both the frequency and the NAD+ cost of each repair cycle.
The volume of DNA damage PARP1 must handle in aged cells is not arbitrary — it is a direct consequence of the mitochondrial decline covered in our guide to NMN and mitochondrial function, which in turn stems from the NAD+ shortage explained in our article on why NAD+ declines with age.
What PARP1 Hyperactivation Looks Like in Practice
When PARP1 is chronically overactivated — as in aged tissue with sustained oxidative stress — the consequences extend beyond NAD+ depletion.
Parthanatos is the term for PARP1-mediated cell death occurring when PAR chain synthesis is so extensive that it depletes NAD+ catastrophically, triggering mitochondrial depolarisation and cell death. This is not a routine occurrence in healthy ageing, but the degree of PARP1 overactivation in aged neuronal and cardiovascular tissue is sufficient to contribute to tissue atrophy over time.
Incomplete repair is the more common consequence. Without sufficient NAD+, PARP1 binds to damage sites and initiates PAR chain synthesis, but chains are short and repair proteins are recruited less efficiently. DNA repair becomes slower and less complete, allowing mutations to accumulate — the mechanistic link between NAD+ deficiency and genomic instability.
Mat Stuckey: "Incomplete repair is the one that concerned me most personally. It is not a dramatic failure. It is a subtle, cumulative one. Over years and decades, every repair event that resolves slightly less cleanly than it should leaves a small residue. The cells age. And the substrate that would have made the repair more complete — NAD+ — is the same substrate that NMN replenishes. That is a compelling argument for starting supplementation before the deficit becomes severe."
How NMN Supports the PARP1-NAD+ System
NMN addresses the PARP1-NAD+ relationship by expanding total cellular NAD+ availability, reducing competition between PARP1 and sirtuins, and improving the efficiency of each repair event.
The NAMPT bypass: NMN enters the NAD+ biosynthetic pathway downstream of NAMPT, the rate-limiting enzyme that declines with age. Supplementing niacin or nicotinamide still requires the NAMPT step, making them subject to the same bottleneck driving the NAD+ deficit. NMN sidesteps that bottleneck and is converted directly to NAD+ by NMNAT enzymes.
In experimental models: A 2013 study demonstrated that raising NAD+ in aged mice restored markers of cellular youth, including DNA repair efficiency. Studies in human cells have shown that NMN-treated cells repair UV-induced DNA damage more rapidly than untreated controls, with the effect attributed to restored PARP1 substrate availability.
Importantly, NMN does not specifically activate or inhibit PARP1. It provides more NAD+, allowing PARP1 to function at the rate the repair burden demands without depleting the pool available to sirtuins and mitochondrial enzymes. The goal is sufficiency — enough NAD+ that the competition between critical enzyme families is resolved.
NMN and the Broader DNA Repair Network
PARP1 is the most NAD+-dependent component of DNA repair, but the broader network also benefits from NAD+ restoration:
| Pathway | Relevant enzyme | NAD+ dependency |
|---|---|---|
| Base excision repair (BER) | PARP1, PARP2 | Direct — NAD+ substrate |
| Non-homologous end joining (NHEJ) | SIRT1 regulates key NHEJ proteins | Indirect via SIRT1 |
| Homologous recombination (HR) | SIRT6 recruited to double-strand break sites | Indirect via SIRT6 |
| Nucleotide excision repair (NER) | SIRT1 activates XPC and other NER factors | Indirect via SIRT1 |
Alpha lipoic acid, another compound studied in the context of antioxidant defence, regenerates glutathione and reduces the oxidative burden that generates the DNA damage PARP1 must repair in the first place. Our NAD+ Activator Bundle combines NMN with alpha lipoic acid for this reason — addressing both the repair capacity and the source of the damage simultaneously.
For those specifically interested in DNA repair and protection supplements, our range covers the compounds most studied in these pathways at research-relevant dosages.
The Longevity Formulas team: "We are a small UK brand and we do not have the marketing budget of larger supplement companies. What we do have is a genuine obsession with the underlying science. Pages like this one are our attempt to share what we have learned — not to sell a product, but because understanding the mechanism is what makes the difference between taking a supplement hopefully and taking it purposefully. We think purposeful supplementation is the only kind worth doing."
Summary
PARP1 is the primary enzyme responsible for detecting DNA strand breaks and initiating repair, consuming multiple NAD+ molecules per repair event.
As NAD+ declines with age, PARP1 and sirtuins compete for the same depleted substrate, impairing both DNA repair and the sirtuin-dependent regulation of ageing processes. Accumulated oxidative damage from declining mitochondrial efficiency, persistent telomere erosion, and reduced base excision repair capacity all increase the DNA damage burden that PARP1 must address, intensifying NAD+ consumption further.
NMN supplementation raises NAD+ by bypassing the age-related NAMPT bottleneck, restoring the substrate pool available to PARP1 without inhibiting its activity, and alleviating the competition with sirtuins that drives the accelerated genomic instability of ageing.
For the complete picture of what NMN does across cellular systems, see our NMN Guide.
Reviewed by the Longevity Formulas team. Referenced studies are catalogued on our clinical research on NMN page.
